[Federal Register Volume 84, Number 32 (Friday, February 15, 2019)]
[Notices]
[Pages 4466-4467]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02521]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The grant applications and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-CE-19-004, Etiologic and 
Effectiveness Research To Address Polysubstance Impaired Driving.
    Date: May 7-8, 2019.
    Time: 8:30 a.m.-5:30 p.m., EDT.
    Place: Atlanta Marriott Buckhead and Conference Center, 3405 Lenox 
Road NE, Atlanta, GA 30326.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Mikel Walters, Ph.D., Scientific 
Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F-63, 
Atlanta, Georgia 30341, Telephone (404) 639-0913, [email protected].
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and

[[Page 4467]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-02521 Filed 2-14-19; 8:45 am]
 BILLING CODE 4163-18-P